Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Sell |
144,281
-27,690
| -16% | -$2.16M | 0.01% | 1407 |
|
|
2025
Q4 | $13.6M | Buy |
171,971
+67,991
| +65% | +$5.89M | 0.01% | 1330 |
|
|
2025
Q3 | $9.52M | Buy |
103,980
+84,421
| +432% | +$6.88M | 0.01% | 1525 |
|
|
2025
Q2 | $1.28M | Sell |
19,559
-8,813
| -31% | -$574K | ﹤0.01% | 3023 |
|
|
2025
Q1 | $1.9M | Sell |
28,372
-6,997
| -20% | -$418K | ﹤0.01% | 2754 |
|
|
2024
Q4 | $1.96M | Buy |
35,369
+7,871
| +29% | +$452K | ﹤0.01% | 2842 |
|
|
2024
Q3 | $1.64M | Buy |
27,498
+11,056
| +67% | +$674K | ﹤0.01% | 2834 |
|
|
2024
Q2 | $1.05M | Sell |
16,442
-1,736
| -10% | -$113K | ﹤0.01% | 2880 |
|
|
2024
Q1 | $1.26M | Buy |
18,178
+3,881
| +27% | +$234K | ﹤0.01% | 2847 |
|
|
2023
Q4 | $788K | Buy |
14,297
+5,731
| +67% | +$316K | ﹤0.01% | 3038 |
|
|
2023
Q3 | $497K | Sell |
8,566
-2,111
| -20% | -$122K | ﹤0.01% | 3066 |
|
|
2023
Q2 | $575K | Buy |
10,677
+4,382
| +70% | +$194K | ﹤0.01% | 3272 |
|
|
2023
Q1 | $250K | Sell |
6,295
-1,676
| -21% | -$70.7K | ﹤0.01% | 3597 |
|
|
2022
Q4 | $321K | Buy |
7,971
+1,036
| +15% | +$38.9K | ﹤0.01% | 3468 |
|
|
2022
Q3 | $223K | Sell |
6,935
-890
| -11% | -$30.5K | ﹤0.01% | 3736 |
|
|
2022
Q2 | $232K | Sell |
7,825
-4,691
| -37% | -$135K | ﹤0.01% | 3763 |
|
|
2022
Q1 | $352K | Buy |
12,516
+3,881
| +45% | +$145K | ﹤0.01% | 3736 |
|
|
2021
Q4 | $398K | Buy |
8,635
+2,673
| +45% | +$115K | ﹤0.01% | 3944 |
|
|
2021
Q3 | $196K | Sell |
5,962
-621
| -9% | -$19.3K | ﹤0.01% | 4124 |
|
|
2021
Q2 | $231K | Buy |
6,583
+5,121
| +350% | +$174K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $53K | Sell |
1,462
-1,444
| -50% | -$45.2K | ﹤0.01% | 4677 |
|
|
2020
Q4 | $84K | Buy |
2,906
+1,413
| +95% | +$40.5K | ﹤0.01% | 5664 |
|
|
2020
Q3 | $42K | Sell |
1,493
-3,508
| -70% | -$104K | ﹤0.01% | 5705 |
|
|
2020
Q2 | $162K | Buy |
5,001
+553
| +12% | +$19.8K | ﹤0.01% | 5181 |
|
|
2020
Q1 | $181K | Sell |
4,448
-1,787
| -29% | -$95K | ﹤0.01% | 4814 |
|
|
2019
Q4 | $384K | Sell |
6,235
-77,771
| -93% | -$5.15M | ﹤0.01% | 4655 |
|
|
2019
Q3 | $6.12M | Buy |
84,006
+69,836
| +493% | +$5.23M | 0.01% | 1765 |
|
|
2019
Q2 | $1.17M | Buy |
14,170
+11,561
| +443% | +$822K | ﹤0.01% | 3441 |
|
|
2019
Q1 | $184K | Sell |
2,609
-37,611
| -94% | -$2.21M | ﹤0.01% | 5190 |
|
|
2018
Q4 | $1.81M | Sell |
40,220
-1,354
| -3% | -$71K | ﹤0.01% | 2766 |
|
|
2018
Q3 | $2.35M | Buy |
41,574
+20,569
| +98% | +$1.26M | ﹤0.01% | 2588 |
|
|
2018
Q2 | $1.4M | Sell |
21,005
-9,135
| -30% | -$570K | ﹤0.01% | 3026 |
|
|
2018
Q1 | $1.75M | Buy |
30,140
+4,263
| +16% | +$271K | ﹤0.01% | 2719 |
|
|
2017
Q4 | $1.67M | Sell |
25,877
-2,153
| -8% | -$134K | ﹤0.01% | 2854 |
|
|
2017
Q3 | $1.47M | Buy |
28,030
+12,636
| +82% | +$603K | ﹤0.01% | 2973 |
|
|
2017
Q2 | $720K | Sell |
15,394
-2,752
| -15% | -$133K | ﹤0.01% | 3645 |
|
|
2017
Q1 | $899K | Sell |
18,146
-5,136
| -22% | -$288K | ﹤0.01% | 3336 |
|
|
2016
Q4 | $1.41M | Buy |
23,282
+14,245
| +158% | +$871K | ﹤0.01% | 3330 |
|
|
2016
Q3 | $600K | Buy |
9,037
+3,914
| +76% | +$245K | ﹤0.01% | 3729 |
|
|
2016
Q2 | $286K | Sell |
5,123
-9,033
| -64% | -$439K | ﹤0.01% | 4172 |
|
|
2016
Q1 | $476K | Buy |
14,156
+13,729
| +3,215% | +$466K | ﹤0.01% | 4177 |
|
|
2015
Q4 | $19K | Sell |
427
-505
| -54% | -$21.7K | ﹤0.01% | 6502 |
|
|
2015
Q3 | $37K | Buy |
932
+191
| +26% | +$10.9K | ﹤0.01% | 5624 |
|
|
2015
Q2 | $46K | Sell |
741
-9,760
| -93% | -$581K | ﹤0.01% | 5589 |
|
|
2015
Q1 | $657K | Sell |
10,501
-2,425
| -19% | -$148K | ﹤0.01% | 3487 |
|
|
2014
Q4 | $729K | Buy |
12,926
+12,655
| +4,670% | +$558K | ﹤0.01% | 3468 |
|
|
2014
Q3 | $7K | Buy |
271
+163
| +151% | +$4.88K | ﹤0.01% | 6409 |
|
|
2014
Q2 | $4K | Buy |
+108
| New | +$3.39K | ﹤0.01% | 6514 |
|
|
2013
Q3 | – | Sell |
-229
| Closed | -$2K | – | 6786 |
|
|
2013
Q2 | $2K | Buy |
+229
| New | +$1.6K | ﹤0.01% | 6514 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
